Related Experiment Video

Updated: Aug 27, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

Standard antifungal therapy in neutropenic patients

M Aoun1

  • 1Département des Maladies Infectieuses et Laboratoire de Microbiologie, Institut Jules Bordet, rue Héger-Bordet 1, 1000 Brussels, Belgium. nathalie.cardinal@bordet.be

International Journal of Antimicrobial Agents
|October 29, 2000
PubMed

Insights

Amphotericin B is the gold standard for treating fungal infections in neutropenic patients. Lipid formulations offer improved safety and tolerability compared to older antifungal agents.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Fungal infections pose a significant threat to patients experiencing prolonged neutropenia.
  • Amphotericin B is a broad-spectrum, fungicidal agent and the established standard for treatment.
  • Limitations of conventional amphotericin B include a narrow therapeutic index and significant toxicity.

Purpose of the Study:

  • To review the current landscape of antifungal therapies for neutropenic patients.
  • To highlight the advantages of newer lipid formulations of amphotericin B.
  • To discuss the declining role of 5-fluorocytosine and the utility of azoles.

Main Methods:

  • Literature review of antifungal agents used in neutropenic patients.
  • Comparative analysis of efficacy, toxicity, and administration of key antifungal drugs.
  • Discussion of clinical considerations for selecting antifungal therapy.

Main Results:

  • Lipid formulations of amphotericin B demonstrate improved patient tolerance and reduced toxicity.
  • 5-fluorocytosine use is decreasing due to its medullary toxicity.
  • Fluconazole and itraconazole are fungistatic options suitable for stable patients.

Conclusions:

  • Lipid formulations of amphotericin B represent a safer alternative to conventional amphotericin B.
  • Antifungal treatment selection should consider patient stability, pathogen spectrum, and drug toxicity.
  • Ongoing research aims to further optimize antifungal strategies for immunocompromised individuals.

More Related Videos

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...